ExpreS2ion Biotech Holding AB (publ) (OM: EXPRS2)
Health Care · Biotechnology · SE
Skr1.40
-2.44% today · -93.7% 1Y
ExpreS2ion Biotech Holding AB (publ) (OM: EXPRS2) operates in the Biotechnology industry within the Health Care sector. The company is valued at $3.51M and employs 19 people.
Over the last twelve months the share price has lost 93.7%, trading between 1.22 and 24.45.
Tweenvest scores ExpreS2ion Biotech Holding AB (publ) across four factors: quality 27/100, value 59/100, growth 100/100. Its strongest factor is growth.
EXPRS2 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $3.51M
- Revenue (TTM)
- $2.50M
- P/E
- —
- EPS
- —
- Dividend yield
- —
- Beta (5Y)
- 2.17
- 52-week high
- Skr24.45
- 52-week low
- Skr1.22
- Avg volume (3M)
- —
- Shares outstanding
- 23.75M
- Employees
- 19
- Next earnings
- —
About ExpreS2ion Biotech Holding AB (publ)
Based in Horsholm, Denmark, ExpreS2ion Biotech Holding AB, along with its subsidiary ExpreS2ion Biotechnologies, specializes in creating and manufacturing complex proteins for use in vaccines and diagnostic products. The company's development pipeline includes a capsid virus-like particle COVID-19 vaccine, an influenza vaccine, and a breast cancer vaccine, all of which are currently undergoing Phase II clinical trials. ExpreS2ion is also engaged in developing a malaria vaccine. Furthermore, the company extends its reach by licensing its proprietary ExpreS2 platform to various research organizations and pharmaceutical businesses. ExpreS2ion Biotech Holding AB commenced operations in 2015.
- ISIN
- SE0023261292
- Founded
- 2015
- Listed since
- Jul 29, 2016
- Exchange
- OMX Nordic Exchange Stockholm
- Currency
- SEK
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $468.22B | $264.96 | +1.20% |
| Amgen Inc.NasdaqGS: AMGN | $237.52B | $439.33 | +1.29% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $181.18B | $146.12 | +1.86% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $138.91B | $548.05 | +1.44% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.28B | $834.04 | +0.90% |
| argenx SEENXTBR: ARGX | $65.85B | €902.00 | +1.90% |
| Moderna, Inc.NasdaqGS: MRNA | $57.92B | $145.13 | +0.04% |
| CSL LimitedASX: CSL | $57.77B | AU$168.30 | -1.69% |
Figures last refreshed Aug 18, 2026.